Tehran, Nov 25 (Prensa Latina) Iran rejected on Wednesday the possibility of another round of negotiations on the Joint Comprehensive Plan of Action (JCPOA) or nuclear deal and demanded respect for the current one.
Moscow, Nov 24 (Prensa Latina) The anti-submarine ship 'Admiral Vinogradov', of the Russian Pacific fleet, intercepted a US destroyer on Tuesday in order to prevent it from violating the national borders, the Defense Ministry reported.
Doha, Nov 23 (Prensa Latina) The US Secretary of State, Mike Pompeo, said here his country has still the tools to fulfill the commitments made by President Donald Trump to withdraw troops from Iraq and Afghanistan.
Riyadh, Nov 22 (Prensa Latina) While the G-20 Summit in Riyadh advocated solidarity against Covid-19, Donald Trump demanded that the United States should be the first to receive the antidote, social networks released on Sunday.
Tehran, Nov 22 (Prensa Latina) The International Atomic Energy Organization (IAEA) confirmed in a report that there is full cooperation with Iran.
Baghdad, Nov 20 (Prensa Latina) The Fatah Alliance ('Conquest', in Arabic) expressed its rejection of the partial withdrawal of US troops from the country and demanded their total withdrawal.
Tehran, Nov 19 (Prensa Latina) The director of the Center for Strategic Studies and International Relations of Iran, Amir Mousavi, warned on Thursday about the danger of Donald Trump's last days in the presidency of the United States for the region.
Washington, Nov 18 (Prensa Latina) Just 12 percent of voters in the United States support President Donald Trump's refusal to acknowledge his defeat against Joe Biden on November 3rd.
Tehran, Nov 18 (Prensa Latina) Iran will return to what is stipulated in the nuclear pact if the United States guarantees its commitments, said the Foreign Minister of the Islamic Republic, Mohammad Yavad Zarif, in an interview published today in a local newspaper.
Washington, Nov 16 (Prensa Latina) The Moderna biotechnology company of the United States has announced that its SARS-CoV-2 vaccine has showed an effectiveness of 94.5 percent during the third phase of clinical trials.
|By the minute||Most read|